/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

M

Min Yuen Teo

Memorial Sloan Kettering Cancer Center(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

222

Papers

4.6K

Citations

28

h-index

47

i10-index

Min Yuen Teo is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Bladder and Urothelial Cancer Treatments & Urinary and Genital Oncology Studies & Cancer Immunotherapy and Biomarkers. The author has an h-index of 28, co-authored 189 publications.

ORCID: 0000-0003-2511-6731

Research Topics

Bladder and Urothelial Cancer Treatments Urinary and Genital Oncology Studies Cancer Immunotherapy and Biomarkers Cancer Genomics and Diagnostics Epigenetics and DNA Methylation

Papers by this author

works

Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma

2024 · New England Journal of Medicine · 132 citations

https://doi.org/10.1056/nejmoa2401726

Andrea B. Apolo Karla V. Ballman Guru Sonpavde Stephanie Berg

FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation

2022 · Nature Communications · 37 citations

https://doi.org/10.1038/s41467-022-34251-3

Joshua I. Warrick Wenhuo Hu Hironobu Yamashita Vonn Walter

Differential NEUROD1, ASCL1, and POU2F3 Expression Defines Molecular Subsets of Bladder Small Cell/Neuroendocrine Carcinoma With Prognostic Implications

2024 · Modern Pathology · 16 citations

https://doi.org/10.1016/j.modpat.2024.100557

Dilara Akbulut Karissa Whiting Min Yuen Teo Jacob E. Tallman

Clinical Outcomes, Genomic Heterogeneity, and Therapeutic Considerations Across Histologic Subtypes of Urothelial Carcinoma

2025 · European Urology · 13 citations

https://doi.org/10.1016/j.eururo.2025.04.008

Carissa Chu Ziyu Chen Karissa Whiting Irina Ostrovnaya

Lessons from the SWITCH trial: changing glucocorticoids in the management of metastatic castration-resistant prostate cancer (mCRPC)

2018 · British Journal of Cancer · 6 citations

https://doi.org/10.1038/s41416-018-0239-y

Min Yuen Teo Howard I. Scher

1964MO Alliance A031501: AMBASSADOR study of adjuvant pembrolizumab (Pembro) in muscle-invasive urothelial carcinoma (MIUC) vs observation (Obs): Extended follow-up disease-free survival (DFS) results and metastatic (met) disease recurrence distribution

2024 · Annals of Oncology · 0 citations

https://doi.org/10.1016/j.annonc.2024.08.2049

Andrea B. Apolo Karla V. Ballman Guru Sonpavde S. Berg

Research topics

topics

Bladder and Urothelial Cancer Treatments

Urinary and Genital Oncology Studies

Cancer Immunotherapy and Biomarkers

Cancer Genomics and Diagnostics

Epigenetics and DNA Methylation

Chat about Author

Papers

Chat

Click to start Chat